pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$LNTHLantheus Holdings, Inc.

$LNTH100.95+0.01%
North Billerica, MA, USupdated 5h ago
Website ↗SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
2
approvals ytd
0
recalls ytd
0

Pipeline(1)

pipeline depth1 products
Phase 2: 1
1Phase 2
Phase 2
LNTH-2403
Osteosarcoma

📅 Upcoming

Nov 5, 2026
earnings
$LNTH100.95+0.01%
in 3mo
Lantheus Holdings, Inc. earnings
Lantheus Holdings, Inc.
→

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Insider activity

source: SEC Form 4
routine RSU / option mechanics (6)
  • Apr 17, 26tax coverNiedzwiecki Daniel · See Remarks1,911 sh
  • Mar 5, 26tax coverNiedzwiecki Daniel · See Remarks1,283 sh
  • Mar 5, 26tax coverMarshall Robert J. Jr. · CFO and Treasurer1,182 sh
  • Mar 5, 26tax coverMorgan Amanda Michelle · Chief Commercial Officer595 sh
  • Mar 5, 26tax coverBrown Kimberly · Chief Accounting Officer133 sh
  • Mar 5, 26grantMarshall Robert J. Jr. · CFO and Treasurer38,002 sh
🐶 Hiring Signal
next earnings Nov 5, 2026
No open roles indexed yet — view Lantheus Holdings, Inc. jobs →

News

  • Curium strikes up to $8B deal for radiopharma rival Lantheus
    Months after reports first linked Curium to a potential Lantheus takeover, the radiopharma players have made it official with a deal worth up to $8 billion.
    fiercebiotech · 11d ago
identifiers
ticker
$LNTH
SEC CIK
0001521036
country
US
source
sec_tickers
top tags
Oncology1
mentioned in
1news items
entity-linker matched
Data sources
SEC EDGAR
last refreshed 23m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?